US Patent Issued to The Board of Regents of The University of Texas System on April 28 for "EPAC1 activators as HIV latency reversal agents (LRA)" (Texas Inventors)

Press/Media: Expert Comment

PeriodApr 29 2020

Media coverage

1

Media coverage

  • TitleUS Patent Issued to The Board of Regents of The University of Texas System on April 28 for "EPAC1 activators as HIV latency reversal agents (LRA)" (Texas Inventors)
    Media name/outletUS Fed News
    CountryUnited States
    Date4/29/20
    PersonsJia Zhou